Serra-Aracil Xavier, Mora-Lopez Laura, Gomez-Torres Irene, Pallisera-Lloveras Anna, Serra-Pla Sheila, Serracant Anna, Garcia-Nalda Albert, Pino-Perez Oriol, Navarro-Soto Salvador
Colorectal Surgery Unit, General and Digestive Surgery Department, Hospital Universitari Parc, Barcelona, Spain.
Colorectal Dis. 2021 Jun;23(6):1562-1568. doi: 10.1111/codi.15562. Epub 2021 Feb 22.
The COVID-19 pandemic has forced surgeons to adapt their standard procedures. The modifications introduced are designed to favour minimally invasive surgery. The positive results obtained with intracorporeal resection and anastomosis in the right colon and rectum prompt us to adapt these procedures to the left colon. We describe a 'don't touch the bowel' technique and outline the benefits to patients of the use of less surgically aggressive techniques and also to surgeons in terms of the lower emission of aerosols that might transmit the COVID-19 infection.
This was an observational study of intracorporeal resection and anastomosis in left colectomy. We describe the technical details of intracorporeal resection, end-to-end stapled anastomosis and extraction of the specimen through mini-laparotomy in the ideal location.
We present preliminary results of 17 patients with left-sided colonic pathologies, 15 neoplasia and two diverticular disease, who underwent four left hemicolectomies, six sigmoidectomies and seven high anterior resections. Median operating time was 186 min (range 120-280). No patient required conversion to extracorporeal laparoscopy or open surgery. Median hospital stay was 4.7 days (range 3-12 days). There was one case of anastomotic leak managed with conservative treatment.
Intracorporeal resection and end-to-end anastomosis with the possibility of extraction of the specimen by a mini-laparotomy in the ideal location may present benefits and also adapts well to the conditions imposed by the COVID-19 pandemic. Future comparative studies are needed to demonstrate these benefits with respect to extracorporeal anastomosis.
新型冠状病毒肺炎疫情迫使外科医生调整其标准手术流程。所做的调整旨在支持微创手术。右半结肠和直肠的体内切除及吻合术取得的积极成果促使我们将这些手术应用于左半结肠。我们描述了一种“不接触肠管”技术,并概述了采用手术侵袭性较小的技术对患者的益处,以及对外科医生而言在减少可能传播新型冠状病毒肺炎感染的气溶胶排放方面的益处。
这是一项关于左半结肠切除术中体内切除及吻合术的观察性研究。我们描述了体内切除、端端吻合器吻合以及在理想位置通过迷你剖腹术取出标本的技术细节。
我们展示了17例左半结肠病变患者的初步结果,其中15例为肿瘤,2例为憩室病,他们接受了4例左半结肠切除术、6例乙状结肠切除术和7例高位前切除术。中位手术时间为186分钟(范围120 - 280分钟)。无患者需要转为体外腹腔镜手术或开放手术。中位住院时间为4.7天(范围3 - 12天)。有1例吻合口漏,经保守治疗处理。
体内切除和端端吻合,并有可能在理想位置通过迷你剖腹术取出标本,可能具有益处,并且很好地适应了新型冠状病毒肺炎疫情带来的条件。未来需要进行比较研究以证明相对于体外吻合术的这些益处。